UK shareholder meetings calendar - next 7 days
22nd Jan 2026 17:13
| Price | 9.50p on 20-02-2026 at 08:10:06 |
|---|---|
| Change | -0.50p -5% |
| Buy | 10.00p |
| Sell | 9.00p |
| Last Trade: | Buy 10,000.00 at 10.00p |
| Day's Volume: | 4,999 |
| Last Close: | 10.00p |
| Open: | 10.20p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 9.50p - 10.20p |
| 52wk Range: | 5.25p - 12.10p |
| Market Capitalisation: | £583.44m |
| VWAP: | 10.20p |
| Shares in Issue: | 6.14b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 10.00p | Suspected BUY Trade |
16:35:14 - 19-Feb-26 |
| Buy* | 50,005 | 9.975p | Ordinary |
16:10:51 - 19-Feb-26 |
| Buy* | 36,000 | 9.975p | Ordinary |
14:38:29 - 19-Feb-26 |
| Unknown* | 0 | 9.00p | SI Trade |
14:19:13 - 19-Feb-26 |
| Sell* | 200 | 8.50p | Ordinary |
13:41:05 - 19-Feb-26 |
| Sell* | 1,194 | 9.115p | Ordinary |
13:32:51 - 19-Feb-26 |
| Buy* | 1 | 9.88p | Ordinary |
13:12:06 - 19-Feb-26 |
| Unknown* | 87,056 | 9.75p | Ordinary |
13:07:19 - 19-Feb-26 |
| Sell* | 304 | 8.50p | Ordinary |
13:02:23 - 19-Feb-26 |
| Buy* | 3,000 | 9.75p | Ordinary |
12:22:28 - 19-Feb-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Jan 2026 8:22 am | RNS | Chief Strategy Officer and Board appointments |
| 29th Jan 2026 2:13 pm | RNS | Result of Annual General Meeting |
| 28th Jan 2026 4:48 pm | RNS | Grant of Options under Long Term Incentive Scheme |
| 19th Jan 2026 7:00 am | RNS | Half Year Trading Update |
| 6th Jan 2026 7:00 am | RNS | Notice of 2025 Annual General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 29th Dec 2025 1:07 pm | RNS | Results of General Meeting |
| 16th Dec 2025 7:00 am | RNS | Grassmuno® marketing authorisation in Germany |
| 12th Dec 2025 7:00 am | RNS | Authority for allotment of New Shares |
| 11th Dec 2025 7:00 am | RNS | Prelim Results and publication of Annual Report |